Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia
Clinical trial NCT03515707 · WITHDRAWN
Trial details
- NCT number
- NCT03515707
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2022-04-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.